SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes as are the investigational 50-mg oral dose and the injectable 2.4-mg dose (Wegovy), in new research. Data from Novo Nordisk’s OASIS 4 trial suggest that “oral semaglutide 25 mg may represent an efficacious option...
Tag: <span>oral semaglutide</span>
Post
Higher doses of oral semaglutide improves blood sugar control and weight loss
by University of North Carolina Health Care Credit: Unsplash/CC0 Public Domain Diabetes is a progressive disease that affects one’s ability to control blood sugar levels. For many patients, the condition becomes more severe over time and blood sugar levels grow more difficult to manage. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have granted patients more...
Post
Novo Nordisk oral semaglutide trial shows reduction in blood sugar, plus weight loss
March 24, 2023 02:40 PM EDT Updated 13 hours ago R&D Pharma Katherine Lewin News Reporter Novo Nordisk is testing higher levels of its oral version of its GLP-1, semaglutide, and its type 2 diabetes trial results released today show reductions in blood sugar as well as weight loss. In the Phase IIIb trial, Novo...